Clinical Trial Update: Treatment of Malignant Peritoneal Mesothelioma (MESOTIP) [Phase 2]

View source ↗

Summary

The MESOTIP Phase 2 trial for malignant peritoneal mesothelioma has been suspended.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Peritoneal Carcinomatosis
• Peritoneal Mesothelioma

Snippet

Sponsor: Institut du Cancer de Montpellier - Val d'Aurelle | Conditions: Peritoneal Mesothelioma, Peritoneal Carcinomatosis | Phase 2 | Status: SUSPENDED